{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:22:36Z","timestamp":1790180556403,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2024GXNSFAA010126"],"award-info":[{"award-number":["2024GXNSFAA010126"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160589"],"award-info":[{"award-number":["82160589"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011823","name":"Education Department of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013091","name":"Science and Technology Major Project of Guangxi","doi-asserted-by":"publisher","award":["GuikeAA23073013"],"award-info":[{"award-number":["GuikeAA23073013"]}],"id":[{"id":"10.13039\/501100013091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011827","name":"Guangxi Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019974","name":"Nanning Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019974","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biomaterials.2026.124022","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:24:09Z","timestamp":1769531049000},"page":"124022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Regulating HIF-2\u03b1 stabilization with an intelligent switchable nanoplatform for tumor immunity reprogramming and enhanced therapy"],"prefix":"10.1016","volume":"330","author":[{"given":"Zelun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangchun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibiao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2099-2652","authenticated-orcid":false,"given":"Xiaofeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biomaterials.2026.124022_bib1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124022_bib2","first-page":"229","article-title":"Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10504","key":"10.1016\/j.biomaterials.2026.124022_bib3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","article-title":"The lancet commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment","volume":"406","author":"Chan","year":"2025","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124022_bib4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2021.05.032","article-title":"Hypoxia is a key regulator in liver cancer progression","volume":"75","author":"Ma","year":"2021","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124022_bib5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/hep.32419","article-title":"Hypoxia-driven immunosuppression by treg and type-2 conventional dendritic cells in hcc","volume":"76","author":"Suthen","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.biomaterials.2026.124022_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.34133\/bmef.0080","article-title":"Recent advances and future directions in sonodynamic therapy for cancer treatment","volume":"2024","author":"Datta","year":"2024","journal-title":"BME Front"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s12951-025-03524-6","article-title":"An oxygen-generating nanoplatform remodels the immunosuppressive tumor microenvironment via synergistic lactate depletion and sonodynamic therapy","volume":"23","author":"Tang","year":"2025","journal-title":"J. Nanobiotechnology"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124022_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"Easl clinical practice guidelines on the management of hepatocellular carcinoma","volume":"82","author":"Sangro","year":"2025","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib9","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1186\/s12951-024-02995-3","article-title":"Synergistic sdt\/cuproptosis therapy for liver hepatocellular carcinoma: enhanced antitumor efficacy and specific mechanisms","volume":"22","author":"Sun","year":"2024","journal-title":"J. Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12943-025-02378-8","article-title":"The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional chinese medicine","volume":"24","author":"Su","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s42003-025-07896-1","article-title":"Redefining the role of hypoxia-inducible factors (hifs) in oxygen homeostasis","volume":"8","author":"Arias","year":"2025","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41420-025-02682-8","article-title":"Empowering hypoxia to convert cold tumors into hot tumors for breast cancer immunotherapy","volume":"11","author":"Liu","year":"2025","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s11658-022-00408-7","article-title":"The transition from hif-1 to hif-2 during prolonged hypoxia results from reactivation of phds and hif1a mrna instability","volume":"27","author":"Jaskiewicz","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124022_bib14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s12276-024-01180-8","article-title":"Hypoxia, oxidative stress, and the interplay of hifs and nrf2 signaling in cancer","volume":"56","author":"Bae","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib15","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s42003-024-06581-z","article-title":"Differential but complementary roles of hif-1alpha and hif-2alpha in the regulation of bone homeostasis","volume":"7","author":"Lee","year":"2024","journal-title":"Commun. Biol."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124022_bib16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2004.06.001","article-title":"Siah2 regulates stability of prolyl-hydroxylases, controls hif1alpha abundance, and modulates physiological responses to hypoxia","volume":"117","author":"Nakayama","year":"2004","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124022_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105420","article-title":"Deletion of prolyl hydroxylase domain-containing enzyme 3 (phd3) in zebrafish facilitates hypoxia tolerance","volume":"299","author":"Liao","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"692","key":"10.1016\/j.biomaterials.2026.124022_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abf6685","article-title":"Oxygen-dependent changes in binding partners and post-translational modifications regulate the abundance and activity of hif-1alpha\/2alpha","volume":"14","author":"Daly","year":"2021","journal-title":"Sci. Signal."},{"key":"10.1016\/j.biomaterials.2026.124022_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.761218","article-title":"Nanosonosensitizers with ultrasound-induced reactive oxygen species generation for cancer sonodynamic immunotherapy","volume":"9","author":"Cheng","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124022_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120822","article-title":"A hypoxia responsive nanoassembly for tumor specific oxygenation and enhanced sonodynamic therapy","volume":"275","author":"Yang","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biomaterials.2026.124022_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117194","article-title":"Transforming the \"cold\" tumors to \"hot\" tumors: strategies for immune activation","volume":"241","author":"Kong","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biomaterials.2026.124022_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114614","article-title":"The tumor epr effect for cancer drug delivery: current status, limitations, and alternatives","volume":"191","author":"Sun","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124022_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2022.09.002","article-title":"Stealth nanoparticles in oncology: facing the peg dilemma","volume":"351","author":"Zalba","year":"2022","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124022_bib25","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1021\/acsami.2c20388","article-title":"Cancer-responsive multifunctional nanoplatform based on peptide self-assembly for highly efficient combined cancer therapy by alleviating hypoxia and improving the immunosuppressive microenvironment","volume":"15","author":"Wu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124022_bib26","doi-asserted-by":"crossref","first-page":"13557","DOI":"10.1021\/acsanm.4c02040","article-title":"Hollow manganese dioxide nanoparticles for drug delivery and imaging","volume":"7","author":"Liu","year":"2024","journal-title":"ACS Appl. Nano Mater."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124022_bib27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1755-148X.2009.00628.x","article-title":"Inhibition of siah2 ubiquitin ligase by vitamin k3 (menadione) attenuates hypoxia and mapk signaling and blocks melanoma tumorigenesis","volume":"22","author":"Shah","year":"2009","journal-title":"Pigment Cell Melanoma Res."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124022_bib28","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41419-019-2155-3","article-title":"Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through hif\/hey1\/pink1 pathway","volume":"10","author":"Kung-Chun","year":"2019","journal-title":"Cell Death Dis."},{"issue":"22","key":"10.1016\/j.biomaterials.2026.124022_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201734","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12951-023-02067-y","article-title":"Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-pd-1\/pd-l1 for residual tumors immunotherapy after rfa","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Nanobiotechnology"},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124022_bib31","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1158\/1078-0432.CCR-17-2725","article-title":"Cox-2\/pge2 axis regulates hif2alpha activity to promote hepatocellular carcinoma hypoxic response and reduce the sensitivity of sorafenib treatment","volume":"24","author":"Dong","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","article-title":"Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124022_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.tibs.2025.06.005","article-title":"The hif axes in cancer: angiogenesis, metabolism, and immune-modulation","volume":"50","author":"Acuna-Pilarte","year":"2025","journal-title":"Trends Biochem. Sci."},{"issue":"40","key":"10.1016\/j.biomaterials.2026.124022_bib34","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1038\/sj.onc.1203814","article-title":"Hypoxia-induced vegf enhances tumor survivability via suppression of serum deprivation-induced apoptosis","volume":"19","author":"Baek","year":"2000","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124022_bib35","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1007\/s00018-017-2577-y","article-title":"Endothelial cell apoptosis in angiogenesis and vessel regression","volume":"74","author":"Watson","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biomaterials.2026.124022_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175586","article-title":"The role of vegf in cancer-induced angiogenesis and research progress of drugs targeting vegf","volume":"949","author":"Ghalehbandi","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The bcl-2 protein family: opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-025-02368-w","article-title":"Nanomedicine in cancer therapeutics: current perspectives from bench to bedside","volume":"24","author":"Abdullah","year":"2025","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124022_bib39","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1053\/j.gastro.2022.02.024","article-title":"Stromal hif2 regulates immune suppression in the pancreatic cancer microenvironment","volume":"162","author":"Garcia","year":"2022","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00018-025-05642-8","article-title":"Targeting hif-2alpha in glioblastoma reshapes the immune infiltrate and enhances response to immune checkpoint blockade","volume":"82","author":"Espinoza","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biomaterials.2026.124022_bib42","article-title":"Tumor-targeting nanomaterials based on metal-organic frameworks mediate tumor immunotherapy by promoting cuproptosis and pyroptosis in hepatocellular carcinoma cells","volume":"32","author":"Yi","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biomaterials.2026.124022_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122944","article-title":"Tumor vascular occlusion by calcium-based thermosensitizer provokes continuous cavitation effect and thermal energy transition efficiency of radiofrequency ablation therapy","volume":"315","author":"Zeng","year":"2025","journal-title":"Biomaterials"},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124022_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202500670","article-title":"Bimetallic ca\/zn nanoagonist remould the immunosuppressive hepatocellular carcinoma microenvironment following incomplete microwave ablation via pyroptosis and the sting signaling pathway","volume":"12","author":"Ling","year":"2025","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124022_bib45","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"Aasld practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124022_bib46","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.23.02745","article-title":"Systemic therapy for advanced hepatocellular carcinoma: Asco guideline update","volume":"42","author":"Gordan","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124022_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13045-024-01647-1","article-title":"Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives","volume":"17","author":"Chen","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124022_bib49","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000209","article-title":"Lenvatinib recruits cytotoxic gzmk+cd8 t cells in hepatocellular carcinoma","volume":"7","author":"Yamada","year":"2023","journal-title":"Hepatol. Commun."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124022_bib50","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/cas.15719","article-title":"Lenvatinib enhances antitumor immunity by promoting the infiltration of tcf1(+) cd8(+) t cells in hcc via blocking vegfr2","volume":"114","author":"Mei","year":"2023","journal-title":"Cancer Sci."},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124022_bib51","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41388-023-02665-y","article-title":"Hypoxia-responsive ppargc1a\/bambi\/acsl5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma","volume":"42","author":"Zhang","year":"2023","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124022_bib52","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/s41401-022-01021-2","article-title":"Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation","volume":"44","author":"Fernandez-Palanca","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124022_bib53","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/liv.15953","article-title":"Lenvatinib in hepatocellular carcinoma: resistance mechanisms and strategies for improved efficacy","volume":"44","author":"Qin","year":"2024","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124022_bib54","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12032-021-01503-z","article-title":"The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors","volume":"38","author":"Une","year":"2021","journal-title":"Medical oncology (Northwood, London, England)"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226000463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226000463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:11:03Z","timestamp":1782187863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226000463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"alternative-id":["S0142961226000463"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124022","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulating HIF-2\u03b1 stabilization with an intelligent switchable nanoplatform for tumor immunity reprogramming and enhanced therapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124022"}}